BMS at ECCO 2022
Intended for U.S. scientific audiences only.
The European Crohn’s and Colitis Organization (ECCO) 2022 Congress is an important opportunity to amplify the latest research and breakthroughs for patients with gastrointestinal (GI) immune-mediated diseases.
Our Data at ECCO 2022
Read more about our key data being presented at the meeting.
At ECCO 2022, 10 company-sponsored abstracts will be presented, demonstrating our commitment to addressing unmet needs for patients living with GI immune-mediated diseases.
We are pursuing pathbreaking science and innovative research to potentially improve outcomes in GI immune-mediated diseases like inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn’s disease. Read how our scientists are addressing some of the most challenging diseases of our time, particularly in gastroenterology.
Learn more about our research in IBD through the resources below.